HCM II Acquisition Corp. (NASDAQ:HOND - Get Free Report) shares traded down 10.9% on Tuesday . The stock traded as low as $19.41 and last traded at $20.21. 2,266,629 shares were traded during mid-day trading, an increase of 210% from the average session volume of 731,711 shares. The stock had previously closed at $22.69.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of HCM II Acquisition in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of "Sell".
View Our Latest Report on HOND
HCM II Acquisition Stock Performance
The business has a 50-day moving average price of $14.75 and a two-hundred day moving average price of $12.38.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Calamos Advisors LLC acquired a new stake in shares of HCM II Acquisition during the first quarter worth $5,288,000. Context Capital Management LLC acquired a new position in shares of HCM II Acquisition during the 1st quarter worth about $3,156,000. Mizuho Securities USA LLC bought a new stake in shares of HCM II Acquisition in the 1st quarter valued at about $271,000. MMCAP International Inc. SPC acquired a new stake in shares of HCM II Acquisition in the 1st quarter valued at approximately $10,310,000. Finally, Magnetar Financial LLC bought a new position in HCM II Acquisition during the 1st quarter worth approximately $20,719,000.
About HCM II Acquisition
(
Get Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.